Tenpoint Therapeutics Appoints Stephen S. Lane as CMO - Takeaway - MDSpire
Feature

Tenpoint Therapeutics Appoints Stephen S. Lane as CMO

ASCRS past-President joins ophthalmic pharmaceutical company

  • April 9, 2026

  • 2 min

Share

  • 1

    Stephen S. Lane, M.D., appointed CMO at Tenpoint Therapeutics.

  • 2

    He has 40 years in ophthalmology and prior leadership at Alcon.

  • 3

    He is a past-President of ASCRS.

  • 4

    His focus will be on innovative therapies for aging eye conditions.

  • 5

    Dr. Lane aims to improve patient outcomes and support eye care professionals.

Original Source(s)

Tenpoint Therapeutics Appoints Stephen S. Lane as CMO

  • April 9, 2026

Related Content

Built for Physicians, Designed for Precision

The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients

  • April 9, 2026

  • 7 min
Built for Physicians, Designed for Precision

The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients

  • April 9, 2026

  • 7 min
Could Red-Light Therapy Change Myopia Care? 

Across 28 trials, pediatric patients receiving therapy had less myopia progression over 12 months, though long-term risks remain under study.